Incyte(INCY)
Incyte is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland.
The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Iclusig | Ponatinib | 2013-07-01 | 2026-2033 | |
| Jakafi | Ruxolitinib | 2011-11-16 | 2026-2041 | |
| Minjuvi | Tafasitamab | 2021-08-26 | ||
| Opzelura | Ruxolitinib | 2021-09-21 | 2026-2041 | |
| Pemazyre | Pemigatinib | 2020-04-17 | 2033-2040 | |
| Zynyz | Retifanlimab | 2023-03-22 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use